Mylan NV Price Prediction and Hype Density Breakdown

MYL -- USA Stock  

Fiscal Quarter End: December 31, 2019  

We analyze noise-free headlines and recent hype associated with Mylan NV which may create opportunities for some arbitrage if properly timed. With Mylan NV hype-based prediction module you can estimate the value of Mylan NV from the prospective of Mylan NV response to recently generated media hype and the effects of current headlines on its competitors. The module also provides analysis of price elasticity to changes in media outlook on Mylan NV over a specific investment horizon. Please see also Mylan NV Basic Forecasting Models to cross-verify your projections.
Horizon     30 Days    Login   to change

Mylan NV After-Hype Price Density Analysis

 Next price density 
      Expected price to next headline 

Mylan NV Estimiated After-Hype Price Volatility

Current Value
December 9, 2019
After-hype Price
Mylan NV is somewhat reliable asset. Analysis and calculation of next after-hype price of Mylan NV is based on 3 months time horizon.

Mylan NV Next Price Analysis

Daily Expected returnPeriod VolatilityHype elasticityRelated hype elasticityAverage news densityRelated news densityNext Expected Hype
 0.19  2.44  0.03   0.01  10 Events / Month8 Events / MonthIn about 10 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility

Mylan NV Hype Timeline

On the 9th of December Mylan NV is traded for 19.02. The entity has historical hype elasticity of -0.03 and average elasticity to hype of competition of -0.01. Mylan NV is estimated to decline in value after the next headline with price expected to drop to 18.99. The average volatility of media hype impact on the company stock price is about 1435.29%. The price depreciation on the next news is expected to be -0.16% where as daily expected return is now at -0.19%. The volatility of related hype on Mylan NV is about 4979.59% with expected price after next announcement by competition of 19.01. About 86.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.74. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Mylan NV has Price/Earnings To Growth (PEG) ratio of 1.0. The entity last dividend was issued on 2007-06-27. The firm had 3:2 split on 2003-10-09. Considering 30-days investment horizon, the next estimated press release will be in about 10 days.
Please see also Mylan NV Basic Forecasting Models to cross-verify your projections.

Mylan NV Related Hype Analysis

At Risk
Eagle Pharmaceuticals 0.31 10 per month 2.16  0.0032  3.21 (3.45)  9.37 
Flexion Therapeutics 0.20 9 per month 2.18  0.23  5.27 (4.03)  12.88 
Endo International Plc(0.22) 8 per month 6.01  0.08  12.54 (11.46)  43.25 
Elanco Animal Health Incorporat 0.82 11 per month 1.68 (0.0213)  2.73 (4.29)  10.59 
Aurora Cannabis(0.18) 9 per month 0.00 (0.09)  12.57 (15.67)  54.79 
Evoke Pharma(0.03) 8 per month 2.87  0.17  7.84 (4.56)  44.68 
Diplomat Pharmacy 0.04 9 per month 0.00 (0.0359)  7.07 (5.68)  57.07 
DURECT Corporation 0.18 9 per month 3.56  0.0306  7.30 (6.36)  21.81 
Evolus Inc Common Stock(1.61) 4 per month 0.00 (0.18)  2.88 (5.90)  16.89 
ENTIA BIOSCIENCES INC 0.00 10 per month 17.04  0.15  50.00 (37.78)  439.48 
Please see also Mylan NV Basic Forecasting Models to cross-verify your projections. Please also try Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.